Evaluation of functional impairment in psoriasis

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 1, 2006, Pages 37-40

  Gaikwad, Rohini ^a   Deshpande, Sharmishtha ^a   Raje, Swati ^a   Dhamdhere, D V ^a   Ghate, M R ^a  

^a MIMER Medical College   (India)

Author keywords

Functional impairment; Psoriasis; Psychiatric comorbidity

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DERMATOLOGY; DETERIORATION; DISEASE EXACERBATION; DISEASE SEVERITY; EDUCATION; EMOTIONALITY; FEMALE; FUNCTIONAL DISEASE; HOME ENVIRONMENT; HOSPITAL; HUMAN; HUMAN RELATION; MALE; OCCUPATION; PRURITUS; PSORIASIS; PSYCHIATRY; QUESTIONNAIRE; SOCIAL DISABILITY; STRESS; WORK DISABILITY;

EID: 32044456183     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.19716     Document Type: Article

References (17)

1. Wells KB, Stewart A, Hays RD, Burnam MA, William R, Daniels M, et al. The functioning and well being of depressed patients. JAMA 1989;262:914-9.
2. Seville RH. Psoriasis and stress. Br J Dermatol 1977;97:297-302.
3. Seville RH. Psoriasis and stress II. Br J Dermatol 1978;98:151-3.
4. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751-6.
5. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;32:236-44.
6. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psych 1992;149:1148-56.
7. th ed. Maryland: Williams and Wilkins; 2001.
8. Schrader G, Gordon M, Harcourt R. The usefulness of DSM-III: axis IV and axis V assessments. Am J Psych 1986;143:904-7.
9. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis specific stress. Br J Dermatol 1997;137:755-60.
10. Patil A, Sharma S, Dhavale HS. Coping with psoriasis: need for consultation-liaison. Indian J Dermatol 2002;47:143-6.
11. Fried RG, Friedman S, Paradis C Hatch M, Lynfield Y, Duncanson C, et al. Trivial or terrible? The psychological impact of psoriasis. Int J Dermatol 1995;34:101-5.
12. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo-a comparative study. J Dermatol 2001;28:419-23.
13. Gupta MA, Gupta AK, Kirby S, Weiner HK, Mace TM, Schork NJ, et al. Pruritis in psoriasis: a prospective study of some psychiatric and dermatological correlates. Arch Dermatol 1998;124:1052-7.
14. Renzi C, Picardi A, Abeni D, Agostini E, Baliva G, Pasquini P, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002;138:337-42.
15. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient - membership survey. Arch Dermatol 2001;137:280-4.
16. Ramsay B, O'Reagan M. A survey of social and psychological effect of psoriasis. Br J Dermatol 1988;118:195-201.
17. Spiegel David. Healing words: emotional expression and disease outcome. JAMA 1999;281:1328-9.